HQ Function

Central hub for Loxo at Lilly's oncology drug discovery, translational research, and clinical development programs, specializing in targeted therapies.

Notable Features:

State-of-the-art laboratory facilities and collaborative workspaces designed to accelerate innovative cancer research.

Work Culture:

Retains a biotech-like agility and strong scientific focus within the larger Eli Lilly framework. Emphasizes rapid innovation, patient impact, and collaborative teamwork.

HQ Significance:

Crucial R&D site for Lilly's precision oncology strategy, building on Loxo's legacy of groundbreaking targeted drug development and approvals.

Values Reflected in HQ: Dedication to scientific rigor, innovation in precision medicine, urgency in addressing patient needs, and a collaborative approach to solving complex cancer challenges.

Location:

As a research and development group within Eli Lilly and Company, Loxo Oncology's work is supported by Lilly's extensive global infrastructure. This includes global clinical trial operations across numerous countries, worldwide regulatory affairs, manufacturing capabilities, and commercial reach for its approved medicines. While Loxo at Lilly's primary R&D sites are in the U.S., its impact and the reach of its therapies are global through the Eli Lilly network.

Street Address:

200 Commons, Suite 200

City:

Stamford

State/Province:

CT

Country:

USA